Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Roth

Showing results (781-790 of 940) with videos related to

Pageof 94
Sort By:
Arthritis and Rheumatism|May 7, 2011
Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung diseaseMichael D Roth, Chi-Hong Tseng, Philip J Clements, et al.
Arthritis and Rheumatism|May 28, 2011
Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo GroupDinesh Khanna, Chi-Hong Tseng, Niloofar Farmani, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 5, 2017
Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and IIElizabeth R Volkmann, Donald P Tashkin, Ning Li, et al.
Chest|November 7, 2009
Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung studyJonathan Goldin, Robert Elashoff, Hyun J Kim, et al.
Clinical Transplants|October 20, 2000
Kidney transplantation at the University of MiamiG Ciancio, N Contreras, V Esquenazi, et al.
Bioorganic & Medicinal Chemistry|October 1, 1996
Cholecystokinin B antagonists. Synthesis and quantitative structure-activity relationships of a series of C-terminal analogues of CI-988C E Augelli-Szafran, D C Horwell, C Kneen, et al.
Diabetes, Obesity & Metabolism|September 11, 2014
Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodentsJ L Trevaskis, C Sun, J Athanacio, et al.
Journal of Pediatric Urology|December 3, 2024
Adherence to follow-up ten years after hypospadias repairNikhil V Batra, Joshua Heiman, Jeremy Koehlinger, et al.
Journal of Proteomics|May 22, 2024
SHIP1 modulation and proteome characterization of microgliaErpan Ahat, Zanyu Shi, Shaoyou Chu, et al.
British Journal of Cancer|March 28, 2003
EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancerJ Van den Brande, P Schöffski, J H M Schellens, et al.
Pageof 94

Showing results (781-790 of 940) with videos related to

Sort By:
Pageof 94
Arthritis and Rheumatism|May 7, 2011
Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung diseaseMichael D Roth, Chi-Hong Tseng, Philip J Clements, et al.
Arthritis and Rheumatism|May 28, 2011
Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo GroupDinesh Khanna, Chi-Hong Tseng, Niloofar Farmani, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 5, 2017
Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and IIElizabeth R Volkmann, Donald P Tashkin, Ning Li, et al.
Chest|November 7, 2009
Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung studyJonathan Goldin, Robert Elashoff, Hyun J Kim, et al.
Clinical Transplants|October 20, 2000
Kidney transplantation at the University of MiamiG Ciancio, N Contreras, V Esquenazi, et al.
Bioorganic & Medicinal Chemistry|October 1, 1996
Cholecystokinin B antagonists. Synthesis and quantitative structure-activity relationships of a series of C-terminal analogues of CI-988C E Augelli-Szafran, D C Horwell, C Kneen, et al.
Diabetes, Obesity & Metabolism|September 11, 2014
Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodentsJ L Trevaskis, C Sun, J Athanacio, et al.
Journal of Pediatric Urology|December 3, 2024
Adherence to follow-up ten years after hypospadias repairNikhil V Batra, Joshua Heiman, Jeremy Koehlinger, et al.
Journal of Proteomics|May 22, 2024
SHIP1 modulation and proteome characterization of microgliaErpan Ahat, Zanyu Shi, Shaoyou Chu, et al.
British Journal of Cancer|March 28, 2003
EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancerJ Van den Brande, P Schöffski, J H M Schellens, et al.
Pageof 94